KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
430 이준식 교수 IAFOST Fellow 선출 과사무실 2003.09.08 13390
429 김선창 교수 6월의 과학기술자 선정 과사무실 2003.09.08 13348
428 김은준 교수 창의과제 신규 선정 과사무실 2003.09.08 14694
427 서연수 교수 생명과학상 수상 과사무실 2003.09.08 14251
426 [KAIST NEWS] 이준식 교수 정년퇴임 과사무실 2003.09.18 20792
425 최길주 교수 美 광생물학회 학술지 부편집장으로 선임 과사무실 2003.09.22 14136
424 [매일경제] 김은준 교수"퍼즐놀이하듯 신경세포 연구" 과사무실 2003.09.23 14298
423 김선창 교수 송암학술상 수상 과사무실 2003.12.23 13851
422 임대식 교수 논문 Nature Cell Biology 게재 1 과사무실 2004.01.26 13650
421 [대덕넷] 임대식 교수"癌 억제하는 유전자 기능 밝혀졌다" 과사무실 2004.02.06 13532
420 김은준 서연수 교수 우수교원 포상 과사무실 2004.02.13 13209
419 강은채 학생 창의활동상 수상 과사무실 2004.02.20 12924
418 변시명 교수 기초과학 교과목 우수강의상 수상 1 과사무실 2004.03.17 13350
417 [매일경제] 고규영 교수 "혈관생성물질 세계 첫 개발" 과사무실 2004.04.14 13512
416 강창원 교수 교무처장 인사발령 과사무실 2004.08.03 12416
415 고규영 교수 국가지정연구실사업 신규과제 선정 과사무실 2004.08.23 12361
414 [대덕넷] 임대식 교수 이달의 과기인상 수상 과사무실 2004.08.30 13002
413 임대식 최길주 교수 승진 인사발령 과사무실 2004.09.01 14539
412 김대수 교수 생명과학과 부임 과사무실 2004.09.01 14402
411 임정훈 박사 한국분자・세포생물학회 우수박사학위논문상 수상 과사무실 2004.09.09 14173
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22